Company Number: 13271120

Analysis Date: 2025-07-29 18:02 UTC

1. Credit Opinion: APPROVE
   Dr Erika Manzo Limited shows a solid financial position with increasing net current assets and shareholders’ funds over a 4-year period. The company is active, compliant with filing deadlines, and has no overdue accounts or returns. The directors have maintained consistent control and governance. The company’s liquidity, evidenced by strong cash balances relative to current liabilities, supports its ability to meet short-term obligations. The business is small but stable with a clear owner-operator structure, which reduces complexity and risk. No adverse director conduct or legal proceedings are noted.

2. Financial Strength:
   The balance sheet presents a healthy and improving financial strength profile. Shareholders’ funds grew from approximately £47k in 2021 to £154k in 2024, reflecting retained earnings and business growth. Net current assets increased significantly to £152,847 in 2024, indicating strong working capital management. Tangible fixed assets are minimal (£1,154) and unlikely to impair liquidity. Current liabilities are modest and stable around £34k, mostly comprising directors’ current accounts and tax liabilities. The company is well-capitalized given its size, with no external borrowings disclosed.

3. Cash Flow Assessment:
   Cash at bank increased from £56k in 2021 to £173k in 2024, indicating strong cash generation and effective cash management. Debtors are low and stable (~£14k), suggesting limited credit risk. The company’s cash significantly exceeds current liabilities, providing a comfortable liquidity buffer. Working capital is very positive and improving, supporting day-to-day operations and potential short-term financing needs. There is no indication of cash flow stress or reliance on external finance.

4. Monitoring Points:

• Maintain regular monitoring of tax liabilities and directors’ current accounts as these constitute the bulk of current liabilities.
• Watch cash flow trends to ensure continued liquidity, especially if business activities or scale increase.
• Monitor any changes in ownership or management, as current control is concentrated with Dr Erika Manzo.
• Keep an eye on debtor aging and any potential increase in credit risk if trade terms change.
• Review business development plans that may affect asset structure or financing needs as the company grows.